针对GD2+脑髓母细胞瘤的GD2+患者的CAR T细胞疗法
Roselia Ciccone1, Concetta Quintarelli1,2, Antonio Camera1
1Department of Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
概括
化学抗原受体 (CAR) 针对GD2的T细胞疗法显示出治疗脑膜母细胞瘤 (MB) 的前景,这是一种常见的儿童脑癌. 这种方法可能会提供比目前的疗法更有效的治疗,副作用更少.
科学领域:
- 儿科瘤学 儿科瘤学
- 免疫治疗是一种免疫疗法.
- 神经瘤学神经瘤学
背景情况:
- 骨髓母细胞瘤 (MB) 是最常见的儿科恶性脑瘤,大约30%的患者预后不佳.
- 目前的标准治疗 (手术,放射,化疗) 可以导致显著的长期认知,神经和内分泌副作用.
研究的目的:
- 调查针对disialoganglioside GD2的化学抗原受体 (CAR) T细胞的潜力,作为更有效的MB治疗方法.
- 评估CAR T细胞疗法是否可以减少与传统MB治疗相关的长期副作用.
主要方法:
- 在使用流细胞计的儿科MB瘤活检中分析了GD2表达.
- GD2表达是由EZH2抑制剂tazemetostat调节的.
- CAR.GD2 T细胞在体外和体内进行了开发和测试,并为安全性添加了自杀基因.
主要成果:
- 在82.68%的MB瘤中表达了GD2,在SHH和G3-G4亚型中水平更高.
- CAR.GD2 T细胞在体外证明了对GD2+ MB细胞的细胞毒性.
- 塔泽梅托斯塔特前期治疗增强了GD2表达,增加了MB细胞对CAR.GD2T细胞的敏感性.
- 在体内研究表明,CAR.GD2 T细胞控制了瘤生长,并在MB小鼠模型中延长了生存时间.
- 自杀基因系统在体内有效地消除了CAR.GD2 T细胞.
结论:
- CAR.GD2 T细胞疗法显示出治疗脑髓母细胞瘤的潜在疗效.
- 一个I/II期临床试验 (NCT05298995) 正在进行中,以评估CAR.GD2治疗在高危MB患者中的安全性和有效性.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
7.9K
05:22Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
3.0K
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
